A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers
Clinical trial NCT06246695 · COMPLETED
Trial details
- NCT number
- NCT06246695
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2022-01-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.